BREXOGEN Inc.
PrivateLast Round
Series C
Sep 1, 2023
Total Funding Raised
$15.37M
Company Overview
BREXOGEN Inc. is a biotechnology company that develops cell-free therapies using its proprietary stem cell-derived exosome platform technology to target incurable diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BREXOGEN Inc. Comps
Public and private peers based on sector, stage, and business model.
BREXOGEN Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 1, 2023 | ||||
| Series A | Sep 16, 2020 |
BREXOGEN Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UTC Investment | Series C, Series A |
| Timefolio Asset Management | Series C, Series A |
| Stonebridge Ventures | Series A |
| KB Securities | Series A |
| Korea Development Bank | Series C |
| Korea Investment Partners | Series C, Series A |
BREXOGEN Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BREXOGEN Inc.'s valuation, stock price, and market status.
